The elF2α kinases PERK and PKR activate glycogen synthase kinase 3 to promote the proteasomal degradation of p53

被引:96
作者
Baltzis, Dionissios
Pluquet, Olivier
Papadakis, Andreas I.
Kazemi, Shirin
Qu, Li-Ke
Koromilas, Antonis E.
机构
[1] INSERM, Bordeaux 33076, France
[2] Univ Penn, Sch Med, Abramson Family Canc Res Inst, Dept Canc Biol, Philadelphia, PA 19104 USA
[3] McGill Univ, Sir Mortimer B Davis Jewish Hosp, Lady Davis Inst Med Res, Montreal, PQ H3T 1E2, Canada
关键词
D O I
10.1074/jbc.M704491200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Phosphorylation of eukaryotic initiation factor 2 alpha(eIF2 alpha) is mediated by a family of kinases that respond to various forms of environmental stress. The eIF2 alpha kinases are critical for mRNA translation, cell proliferation, and apoptosis. Activation of the tumor suppressor p53 results in cell cycle arrest and apoptosis in response to various types of stress. We previously showed that, unlike the majority of stress responses that stabilize and activate p53, induction of endoplasmic reticulum stress leads to p53 degradation through an Mdm2-dependent mechanism. Here, we demonstrate that the endoplasmic reticulum-resident eIF2 alpha kinase PERK mediates the proteasomal degradation of p53 independently of translational control. This role is not specific for PERK, because the eIF2 alpha kinase PKR also promotes p53 degradation in response to double-stranded RNA. We further establish that the eIF2 alpha kinases induce glycogen synthase kinase 3 to promote the nuclear export and proteasomal degradation of p53. Our findings reveal a novel cross- talk between the eIF2 alpha kinases and p53 with implications in cell proliferation and tumorigenesis.
引用
收藏
页码:31675 / 31687
页数:13
相关论文
共 79 条
  • [1] Hypoxia attenuates the p53 response to cellular damage
    Achison, M
    Hupp, TR
    [J]. ONCOGENE, 2003, 22 (22) : 3431 - 3440
  • [2] Arava Yoav, 2003, Methods Mol Biol, V224, P79
  • [3] Role of Noxa in p53-independent fenretinide-induced apoptosis of neuroectodermal tumours
    Armstrong, Jane L.
    Veal, Gareth J.
    Redfern, Christopher P. F.
    Lovat, Penny E.
    [J]. APOPTOSIS, 2007, 12 (03) : 613 - 622
  • [4] Bell John C., 2003, Cancer Cell, V4, P7, DOI 10.1016/S1535-6108(03)00170-3
  • [5] ER stress-regulated translation increases tolerance to extreme hypoxia and promotes tumor growth
    Bi, MX
    Naczki, C
    Koritzinsky, M
    Fels, D
    Blais, J
    Hu, NP
    Harding, H
    Novoa, I
    Varia, M
    Raleigh, J
    Scheuner, D
    Kaufman, RJ
    Bell, J
    Ron, D
    Wouters, BG
    Koumenis, C
    [J]. EMBO JOURNAL, 2005, 24 (19) : 3470 - 3481
  • [6] Post-translational modification of p53 in tumorigenesis
    Bode, AM
    Dong, ZG
    [J]. NATURE REVIEWS CANCER, 2004, 4 (10) : 793 - 805
  • [7] A selective inhibitor-of eIF2α dephosphorylation protects cells from ER stress
    Boyce, M
    Bryant, KF
    Jousse, C
    Long, K
    Harding, HP
    Scheuner, D
    Kaufman, RJ
    Ma, DW
    Coen, DM
    Ron, D
    Yuan, JY
    [J]. SCIENCE, 2005, 307 (5711) : 935 - 939
  • [8] Reactivation of mutant p53 and induction of apoptosis in human tumor cells by maleimide analogs
    Bykov, VJN
    Issaeva, N
    Zache, N
    Shilov, A
    Hultcrantz, M
    Bergman, J
    Selivanova, G
    Wiman, KG
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2005, 280 (34) : 30384 - 30391
  • [9] Small molecules that reactivate mutant p53
    Bykov, VJN
    Selivanova, G
    Wiman, KG
    [J]. EUROPEAN JOURNAL OF CANCER, 2003, 39 (13) : 1828 - 1834
  • [10] Restoration of the tumor suppressor function to mutant p53 by a low-molecular-weight compound
    Bykov, VJN
    Issaeva, N
    Shilov, A
    Hultcrantz, M
    Pugacheva, E
    Chumakov, P
    Bergman, J
    Wiman, KG
    Selivanova, G
    [J]. NATURE MEDICINE, 2002, 8 (03) : 282 - 288